Top Markets
Coin of the day
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rang in Aktien #33743
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Aktienkurs
$4.58
Zuletzt synchronisiert: 2025-05-09
Marktkapitalisierung
$6.98M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel NeuroMetrix, Inc. (NURO)

Kategorie

P/B-Verhältnis für NeuroMetrix, Inc. (NURO)
P/B-Verhältnis zum August 2026 TTM: 0.63
Laut den neuesten Finanzberichten und dem Aktienkurs von NeuroMetrix, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0.63. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 0.19.
P/B-Verlauf für NeuroMetrix, Inc. von 2001 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 0.63 14.62%
2024 0.55 192.82%
2023 0.19 -58.98%
2022 0.45 -89.75%
2021 4.44 -75.68%
2020 18.25 12.96%
2019 16.15 114.43%
2018 7.53 60.49%
2017 4.69 -41.25%
2016 7.99 56.56%
2015 5.10 -86.41%
2014 37.55 94.53%
2013 19.30 284.45%
2012 5.02 44.48%
2011 3.48 -43.94%
2010 6.20 -33.21%
2009 9.28 121.74%
2008 4.19 -78.95%
2007 19.89 -42.10%
2006 34.35 -53.02%
2005 73.10 120.22%
2004 33.20 -302.79%
2003 -16.37 -12.25%
2002 -18.65 0.00%
2001 0.00 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.7944 501.90%
US
5.423 760.25%
US
2.0146 219.57%
IE
3.072 387.31%
US
4.9725 688.78%
US